Amid mounting reports of serious medical complications associated with transvaginal mesh, an advisory panel of the Food and Drug Administration (FDA) has proposed that some of these surgical patches be reclassified as high-risk devices. Transvaginal mesh products, also known as bladder slings, have been used in the surgical treatment of pelvic organ prolapse (POP) and stress urinary incontinence (SUI) in women since the mid-1990s. Transvaginal mesh has also been linked to a high failure rate and an increasing number of complaints of complications including:

  • Infections
  • Internal bleeding
  • Organ injuries
  • Pelvic and vaginal discomfort
  • Recurrence of POP or SUI

The Mobile, Alabama, product liability attorneys at Long & Long are actively investigating claims from women who may have been harmed by transvaginal mesh used in the correction of POP or SUI. The injuries caused by transvaginal mesh require immediate medical attention, including the possibility of revision surgery; complications from transvaginal mesh are thought to have contributed to the wrongful death of at least seven patients. Transvaginal mesh devices are marketed under a number of brand names, although most complaints have focused on transvaginal mesh produced by the following manufacturers:

  • American Medical Systems
  • Boston Scientific
  • C.R. Bard
  • Covidien
  • Ethicon
  • Johnson & Johnson

The FDA has yet to make a decision on the advisory panel’s recommendation to reclassify transvaginal mesh and require new studies on these dangerous medical devices. If you received transvaginal mesh in the treatment of POP or SUI and believe you suffered harm as a result, please contact the Mobile, Alabama, defective product attorneys at Long & Long for your free case evaluation.

Long & Long Mobile Office

301 St. Louis St.
Mobile, AL 36602

Phone: (251) 432-2277

Long & Long Orange Beach Office

27075 Marina Rd.
Orange Beach, AL 36561

Phone: (251) 432-4878

Free Case Review

Contact Us Today